Immune Response Evaluation Through Determination of Type 1, Type 2, and Type 17 Patterns in Patients With Epithelial Ovarian Cancer

Ovarian Cancer Screening

(2012) JOHN R. van NAGELL et al.   CLINICAL OBSTETRICS AND GYNECOLOGY

Tumor-derived interleukin-10 as a prognostic factor in stage III patients undergoing adjuvant treatment with an autologous melanoma cell vaccine

(2011) Amit Mahipal et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Immune Response in Ovarian Cancer: How Is the Immune System Involved in Prognosis and Therapy: Potential for Treatment Utilization

(2011) Nikos G. Gavalas et al.   Clinical & Developmental Immunology

Cytokine analysis as a tool to understand tumour–host interaction in ovarian cancer

(2011) Refika Yigit et al.   EUROPEAN JOURNAL OF CANCER

Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments

(2009) I. Kryczek et al.   BLOOD

Human interleukin 10 receptor 1/IgG1-Fc fusion proteins: immunoadhesins for human IL-10 with therapeutic potential

(2009) Mizue Terai et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

A phase II study of GM-CSF and rIFN-γ1b plus carboplatin for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube and primary peritoneal cancer

(2009) Kathleen M. Schmeler et al.   GYNECOLOGIC ONCOLOGY

Ovarian cancer

(2009) Bryan T Hennessy et al.   LANCET

Anti-Tumor Necrosis Factor Therapy Inhibits Pancreatic Tumor Growth and Metastasis

(2008) J.-H. Egberts et al.   CANCER RESEARCH

Cytokine elevations in acute coronary syndrome and ovarian cancer: A mechanism for the up-regulation of the acute phase proteins in these different disease etiologies

(2008) Peter A. Kavsak et al.   CLINICAL BIOCHEMISTRY

The Biological Functions of T Helper 17 Cell Effector Cytokines in Inflammation

(2008) Wenjun Ouyang et al.   IMMUNITY